The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

ASCO 2019 | How do racial disparities affect multiple myeloma treatment?

Jun 3, 2019

Sikander Ailawadhi, Mayo Clinic, Jacksonville, US, talks to the MM Hub at ASCO 2019, about how racial disparities influence the outcomes of patients with multiple myeloma.

Sikander Ailawadhi discusses the growing complexity in defining racial subgroups, and highlights the need for an acceptance across institutions that the care we deliver is not uniform and this is leading to differences in patient outcomes. He highlights the next step will be to determine whether these underlying factors are the same across all subgroups, or are unique, and then to determine the best route to overcome them. To overcome these issues will involve opening a wider discussion, which this session at ASCO has taken great strides towards achieving.

How do racial disparities affect multiple myeloma treatment?